Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 21412260)

1.

Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.

Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, Baerveldt EM, Ozgur Z, van IJcken WF, Laman JD, Staal FJ, van der Fits L.

J Invest Dermatol. 2011 Jul;131(7):1547-58. doi: 10.1038/jid.2011.53. Epub 2011 Mar 17.

2.

T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.

Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB.

Arch Dermatol Res. 2004 May;295(12):509-16. Epub 2004 Mar 16.

PMID:
15024577
3.

Immunohistochemical staining of surfactant proteins A and B in skin of psoriatic patients before and after narrow-band UVB phototherapy.

Aiad HA, El-Farargy SM, Soliman MM, El-Wahed Gaber MA, El-Aziz Othman SA.

Am J Clin Dermatol. 2012 Oct 1;13(5):341-8. doi: 10.2165/11630720-000000000-00000.

PMID:
22621659
4.

Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.

Rácz E, de Leeuw J, Baerveldt EM, Kant M, Neumann HA, van der Fits L, Prens EP.

Lasers Surg Med. 2010 Mar;42(3):201-10. doi: 10.1002/lsm.20898.

PMID:
20333742
5.
6.

GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4.

Rácz E, Kurek D, Kant M, Baerveldt EM, Florencia E, Mourits S, de Ridder D, Laman JD, van der Fits L, Prens EP.

PLoS One. 2011;6(5):e19806. doi: 10.1371/journal.pone.0019806. Epub 2011 May 17.

7.

Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy.

Rateb AA, Fawzi MM, Abdel Hay RM, Mohammed FN, Amr KS.

Eur J Dermatol. 2012 Jul-Aug;22(4):481-7. doi: 10.1684/ejd.2012.1730.

PMID:
22531960
8.

Effect of narrow-band ultraviolet B phototherapy on p63 and microRNA (miR-21 and miR-125b) expression in psoriatic epidermis.

Gu X, Nylander E, Coates PJ, Nylander K.

Acta Derm Venereol. 2011 Jun;91(4):392-7. doi: 10.2340/00015555-1086.

9.

Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris.

Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):893-900.

PMID:
10365919
10.

Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.

Johnson-Huang LM, Suárez-Fariñas M, Sullivan-Whalen M, Gilleaudeau P, Krueger JG, Lowes MA.

J Invest Dermatol. 2010 Nov;130(11):2654-63. doi: 10.1038/jid.2010.166. Epub 2010 Jun 17.

11.

The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.

Eysteinsdóttir JH, Sigurgeirsson B, Ólafsson JH, Fridriksson T, Agnarsson BA, Davíðsson S, Valdimarsson H, Lúðvíksson BR.

Scand J Immunol. 2013 Dec;78(6):529-37. doi: 10.1111/sji.12114.

PMID:
24111693
12.

[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].

Beani JC, Jeanmougin M.

Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29. Review. French.

PMID:
20110064
13.

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.

Tintle S, Shemer A, Suárez-Fariñas M, Fujita H, Gilleaudeau P, Sullivan-Whalen M, Johnson-Huang L, Chiricozzi A, Cardinale I, Duan S, Bowcock A, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2011 Sep;128(3):583-93.e1-4. doi: 10.1016/j.jaci.2011.05.042. Epub 2011 Jul 16.

14.

TREM-1 as a potential therapeutic target in psoriasis.

Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T, Gulati N, Fuentes-Duculan J, Suárez-Fariñas M, Lowes MA.

J Invest Dermatol. 2013 Jul;133(7):1742-51. doi: 10.1038/jid.2013.68. Epub 2013 Feb 13.

15.

Successful treatment of psoriasis vulgaris with targeted narrow-band ultraviolet B therapy using a new flat-type fluorescent lamp.

Nishida E, Furuhashi T, Kato H, Kaneko N, Shintani Y, Morita A.

Photodermatol Photoimmunol Photomed. 2011 Oct;27(5):248-50. doi: 10.1111/j.1600-0781.2011.00607.x.

PMID:
21950629
16.

Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.

Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.

Br J Dermatol. 2011 Jun;164(6):1383-6. doi: 10.1111/j.1365-2133.2011.10358.x.

PMID:
21466532
17.

Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.

Kikuchi K, Wakamatsu K, Tada Y, Komine M, Ito S, Tamaki K.

Clin Exp Dermatol. 2008 Nov;33(6):750-3. doi: 10.1111/j.1365-2230.2008.02792.x.

PMID:
18954414
18.

Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions.

Nagui NA, Abdel Hay RM, Rashed LA.

Eur J Dermatol. 2011 Nov-Dec;21(6):866-9. doi: 10.1684/ejd.2011.1496.

PMID:
21856559
19.

LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.

Bagel J.

J Drugs Dermatol. 2009 Apr;8(4):351-7.

PMID:
19363853
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk